Cross-check layer: This is openFDA JSON-derived label data. Use the corresponding DailyMed SPL as the canonical label.
| Applications | Product NDCs | Package NDCs | RxCUIs | UNIIs | Routes |
|---|---|---|---|---|---|
| NDA017771 | 11994-090, 11994-091 | 11994-090-36, 11994-090-73, 11994-090-92, 11994-090-01, 11994-090-03, 11994-090-04, 11994-090-05, 11994-090-06, 11994-090-07, 11994-090-09, 11994-090-10, 11994-090-11, 11994-090-12, 11994-090-13, 11994-091-36, 11994-091-73, 11994-091-92, 11994-091-01, 11994-091-03, 11994-091-04, 11994-091-05, 11994-091-06, 11994-091-07, 11994-091-09, 11994-091-10, 11994-091-11, 11994-091-12, 11994-091-13 | A0730CX801 | INTRAVENOUS |
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
WARNINGS: Radiation risks associated with the use of Sodium Pertechnetate Tc 99m Injection are greater in children than in adults and, in general, the younger the child, the greater the risk owing to greater absorbed radiation doses and longer life-expectancy. These greater risks should be taken firmly into account in all benefit-risk assessments involving children. Long-term cumulative radiation exposure may be associated with an increased risk of cancer.
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
ADVERSE REACTIONS: Allergic reactions including anaphylaxis have been reported infrequently following the administration of Sodium Pertechnetate Tc 99m Injection.